Treadwell Therapeutics is a clinical-stage oncology company exploiting cancer cells’ vulnerabilities to develop first-in-class and best-in-class small molecules to address unmet needs in patients with cancer. Harnessing unique innovations from our founders, partners, and the world-class scientists at TIO Discovery, we are advancing a pipeline of novel clinical candidates with pan-cancer potential aimed at genomic instability...
Treadwell Therapeutics is a clinical-stage oncology company exploiting cancer cells’ vulnerabilities to develop first-in-class and best-in-class small molecules to address unmet needs in patients with cancer. Harnessing unique innovations from our founders, partners, and the world-class scientists at TIO Discovery, we are advancing a pipeline of novel clinical candidates with pan-cancer potential aimed at genomic instability and previously untapped immuno-oncology targets.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.